Paperpal Prime Logo

Neuropsychiatric Disease and Treatment : Impact Factor & More

eISSN: 1178-2021pISSN: 1176-6328
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Biological Psychiatry
SNIP
1.09
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Neuropsychiatric Disease and Treatment ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neuropsychiatric Disease and Treatment

Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial
  • 19 Jun 2026
  • Neuropsychiatric Disease and Treatment
Mini-Review: Allicin as a Potential Neuroprotective Compound in Neurological Disorders
  • 18 Jun 2026
  • Neuropsychiatric Disease and Treatment
Modifying Neuropsychiatric and Motor Trajectories in Huntington\u2019s Disease Through an Integrated Neurobehavioral Clinic Model
  • 17 Jun 2026
  • Neuropsychiatric Disease and Treatment
Altered Effective Connectivity Within the Frontoparietal Network in Alzheimer\u2019s Disease and Its Modulation by Acupuncture: A Resting-State fMRI Study
  • 13 Jun 2026
  • Neuropsychiatric Disease and Treatment
Therapeutic Potential of Naive Hair Follicle Stem Cells in Alzheimer\u2019s Disease: A Comprehensive Evaluation of Neuroprotection and Neurogenesis
  • 11 Jun 2026
  • Neuropsychiatric Disease and Treatment
Acupuncture for Early Parkinson\u2019s Motor Symptoms: A Multicenter Randomized Controlled Trial Protocol
  • 11 Jun 2026
  • Neuropsychiatric Disease and Treatment
Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial
  • 19 Jun 2026
  • Neuropsychiatric Disease and Treatment
Mini-Review: Allicin as a Potential Neuroprotective Compound in Neurological Disorders
  • 18 Jun 2026
  • Neuropsychiatric Disease and Treatment
Modifying Neuropsychiatric and Motor Trajectories in Huntington\u2019s Disease Through an Integrated Neurobehavioral Clinic Model
  • 17 Jun 2026
  • Neuropsychiatric Disease and Treatment
Altered Effective Connectivity Within the Frontoparietal Network in Alzheimer\u2019s Disease and Its Modulation by Acupuncture: A Resting-State fMRI Study
  • 13 Jun 2026
  • Neuropsychiatric Disease and Treatment
Therapeutic Potential of Naive Hair Follicle Stem Cells in Alzheimer\u2019s Disease: A Comprehensive Evaluation of Neuroprotection and Neurogenesis
  • 11 Jun 2026
  • Neuropsychiatric Disease and Treatment
Acupuncture for Early Parkinson\u2019s Motor Symptoms: A Multicenter Randomized Controlled Trial Protocol
  • 11 Jun 2026
  • Neuropsychiatric Disease and Treatment

FAQs on Neuropsychiatric Disease and Treatment